Clinical Trial Update: Effect of SVF Derived MSC in DCD Renal Transplantation [Phase 1, Phase 2]

View source ↗

Summary

This update covers Phase 1 and Phase 2 investigations of stromal vascular fraction–derived mesenchymal stem cells in donation-after-circulatory-death renal tran…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Uremia

Drugs mentioned

• SVF-derived mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Fuzhou General Hospital | Conditions: Uremia | Phase 1, Phase 2 | Status: UNKNOWN